Autolus Therapeutics Plc (AUTL)

1.38 -0.06 (-4.17%) USD  |  NASDAQ  |  Jan 16, 15:45
More

Autolus Therapeutics SG&A Expense (TTM): 129.58M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc 5.354M
NuCana Plc 9.964M
Mereo BioPharma Group Plc 25.26M
Bicycle Therapeutics Plc 80.05M
Adaptimmune Therapeutics Plc 90.49M